Data as of Apr 17
| -0.24 / -1.14%|
The 6 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 35.50, with a high estimate of 53.00 and a low estimate of 29.00. The median estimate represents a +70.26% increase from the last price of 20.85.
The current consensus among 6 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.